AUDRA HART: Open Payments
NPI 1013528728 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 33 payments from 13 companies in 2025. Trend: 2023 $118 · 2024 $693 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $136 |
| CVRx, Inc. | 4 | $133 |
| Actelion Pharmaceuticals US, Inc. | 4 | $117 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| AtriCure, Inc. | 2 | $58 |
| PFIZER INC. | 3 | $54 |
| Boston Scientific Corporation | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: LEQVIO, Barostim Neo System, VERQUVO, OPSYNVI, OPSUMIT, ELIQUIS, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, LUX-Dx Insertable Cardiac Monitor.
Industry payments across GA — which companies pay providers there.
